Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Loving-kindness Meditation for Posttraumatic Stress Disorder (PTSD)

This study has been completed.
Information provided by (Responsible Party):
David Kearney, Seattle Institute for Biomedical and Clinical Research Identifier:
First received: May 23, 2012
Last updated: May 24, 2012
Last verified: May 2012
A before and after study of veterans who took part in a 12-week loving-kindness meditation course as an adjunct to their usual care for posttraumatic stress disorder.

Condition Intervention
Posttraumatic Stress Disorder
Behavioral: loving-kindness meditation

Study Type: Interventional
Study Design: Endpoint Classification: Efficacy Study
Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Treatment
Official Title: An Open Pilot Study of Loving-Kindness Meditation for PTSD

Resource links provided by NLM:

Further study details as provided by Seattle Institute for Biomedical and Clinical Research:

Primary Outcome Measures:
  • change in PTSD symptoms [ Time Frame: baseline, post-intervention, 3-month follow-up ] [ Designated as safety issue: Yes ]
    The PTSD symptom-scale interview was performed

  • change in depressive symptoms [ Time Frame: baseline, post-intervention, 3-month follow-up ] [ Designated as safety issue: No ]
    The PROMIS measure for depression was administered

Enrollment: 42
Study Start Date: January 2010
Study Completion Date: June 2011
Primary Completion Date: June 2011 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: loving-kindness meditation Behavioral: loving-kindness meditation
A 12-week duration, 90 minute per session loving-kindness meditation course


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • posttraumatic stress disorder

Exclusion Criteria:

  • psychosis
  • borderline personality disorder
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT01607632

United States, Washington
VA Puget Sound
Seattle, Washington, United States, 98108
Sponsors and Collaborators
Seattle Institute for Biomedical and Clinical Research
Principal Investigator: David Kearney, MD VA Puget Sound
  More Information

Responsible Party: David Kearney, Staff Physician, Seattle Institute for Biomedical and Clinical Research Identifier: NCT01607632     History of Changes
Other Study ID Numbers: 00173 
Study First Received: May 23, 2012
Last Updated: May 24, 2012
Health Authority: United States: Institutional Review Board

Keywords provided by Seattle Institute for Biomedical and Clinical Research:
posttraumatic stress

Additional relevant MeSH terms:
Stress Disorders, Traumatic
Stress Disorders, Post-Traumatic
Trauma and Stressor Related Disorders
Mental Disorders processed this record on October 26, 2016